CIS

Clinical Immunology Society (CIS)

2017 Annual Meeting: Immune Deficiency and Dysregulation North American Conference

Mark your calendars for the 2017 Annual Meeting!

On behalf of the Clinical Immunology Society (CIS), we invite you to attend the 2017 Annual Meeting: Immune Deficiency and Dysregulation North American Conference taking place March 23 – 26, 2017 at The Westin Seattle in Seattle, Washington.

THERE ARE LIMITED ROOMS AVAILABLE AT THE WESTIN FOR MARCH 23 & 24. The nights of March 22 and March 25 are SOLD OUT.

Please contact the CIS Office with any questions at 1.414.224.8095 or
stulley@clinimmsoc.org.

CIS is the key inter-disciplinary organization for the field of clinical immunology and is devoted to fostering developments in the science and practice of clinical immunology. The mission of CIS is to facilitate education, translational research and novel approaches to therapy in clinical immunology and to promote excellence in the care of patients with immunologic/inflammatory disorders. Registration closes March 6. Click below to begin your registration today!

The Annual Meeting and Summer School, Second Edition will provide a venue for the presentation of the newest immune deficiency diseases and the pathogenesis of these defects in molecular terms. The substance of the conference will be cutting edge clinical and basic science research.

This year, the Clinical Immunology Society is proud to offer a new pre-conference session, Summer School, Second Edition: Cases and Controversies. This new session will cover a wide breadth of PID related cases, with discussion focusing on potential diagnostic or management approaches. Registration is open to all who wish to attend; you do not need to present a case to attend. Click below to learn more!

Join us for this momentous occasion that promises to be one of the best conferences on primary immunodeficiency. We look forward to seeing you in Seattle!

Regards,

2017 Annual Meeting Program Committee

Co-Chairs:
Jordan S. Orange, MD, PhD - Baylor College of Medicine
Roshini Sarah Abraham, PhD - Mayo Clinic

Committee:
Steven M. Holland, MD - NIAID, NIH
Sergio D. Rosenzweig, MD, PhD - NIAID, NIH
Kathleen E. Sullivan, MD, PhD - Children's Hospital of Philadelphia
Troy R. Torgerson, MD, PhD - University of Washington